Drug Safety

Risk of Fractures with Glitazones: A Critical Review of the Evidence to Date
pp. 539-547(9)
Authors: Bodmer, Michael; Meier, Christian; Kraenzlin, Marius E.; Meier, Christoph R.

Patient-Controlled Analgesia-Related Medication Errors in the Postoperative Period: Causes and Prevention
pp. 549-559(11)
Authors: Schein, Jeff R.; Hicks, Rodney W.; Nelson, Winnie W.; Sikirica, Vanja; Doyle, D. John

Pharmacokinetic Changes of Psychotropic Drugs in Patients with Liver Disease: Implications for Dose Adaptation
pp. 561-578(18)
Authors: Schlatter, Chantal; Egger, Sabin S.; Tchambaz, Lydia; Krähenbühl, Stephan

Risk Perception and Reasons for Noncompliance in Pharmacovigilance: A Qualitative Study Conducted in Canada
pp. 579-590(12)
Authors: Nichols, Vincent; Thériault-Dubé, Isabelle; Touzin, Julie; Delisle, Jean-François; Lebel, Denis; Bussières, Jean-François; Bailey, Benoît; Collin, Johanne

Statins and Erectile Dysfunction: Results of a Case/Non-Case Study using the French Pharmacovigilance System Database
pp. 591-597(7)
Authors: Do, Catherine; Huyghe, Eric; Lapeyre-Mestre, Maryse; >Jean Louis Montastruc,; Bagheri, Haleh

Identifying Drug-Induced Repolarization Abnormalities from Distinct ECG Patterns in Congenital Long QT Syndrome: A Study of Sotalol Effects on T-Wave Morphology
pp. 599-611(13)
Authors: Graff, Claus; Andersen, Mads P.; Xue, Joel Q.; Hardahl, Thomas B.; Kanters, Jørgen K.; Toft, Egon; Christiansen, Michael; Jensen, Henrik K.; Struijk, Johannes J.

Drug-Induced Changes in the T-Wave Morphology
pp. 613-617(5)
Author: Malik, Marek

The Continuing Unacceptable Marketing of Alka-Seltzer® Containing Aspirin for Stomach-Related Disorders
pp. 619-621(3)
Authors: de Abajo, Francisco J.; Rodríguez, Luis A. García